Skip to content
  • Home
  • About Us
  • Main Business Clinical
    • Main Business Clinical
    • Clinical process
  • Information
    • Newsletter
    • Clinical Trial Information
  • Korea Clinical Trial Status
    • Pharmaceutical Approval Status in Korea
    • Medical Device Approval Status in Korea
  • English
    • English
    • 한국어
Quotation Request
(주)인투인월드 Intoinworld

Connecting people, advancing clinical value

  • Home
  • About Us
  • Main Business
    • Main Business
    • Clinical Trial Process
  • Information
    • Notice
    • Newsletter
    • Clinical Trial Information
      • FDA/EMA Global Submission Strategies
      • Regulatory & Guideline Updates
      • Clinical Trend Insights
      • CRO Knowledge
  • Korea Clinical Trial Status
    • Pharmaceutical Approval Status in Korea
    • Medical Device Approval Status in Korea
  • English
    • English
    • 한국어
Quotation Request
(주)인투인월드 Intoinworld

Connecting people, advancing clinical value

  • 인투인월드인투인월드
  • 2023/05/23
  • Newsletter_EN

[Newsletter] Vol 39. May 2023

Home Newsletter_EN [Newsletter] Vol 39. May 2023

Newsletter Vol 39. This is the May 2023 newsletter.

Newsletter Vol.39Download

Related Posts

인투인월드Newsletter Vol.70 EN

[Newsletter] Vol 70. December 2025

  • 2025/12/19
인투인월드Newsletter Vol.69 EN 1

[Newsletter] Vol 69. November 2025

  • 2025/11/19
인투인월드Newsletter Vol.68 EN 1 1

[Newsletter] Vol 68. October 2025

  • 2025/10/24
인투인월드Newsletter-Vol.66-EN

[Newsletter] Vol 66. August 2025

  • 2025/08/26

Business registration number

425-87-00267

Tel

+82-2-2038-8082

E-mail

intoin@intoinworld.com

CEO

John Choi

Address

10F, 21, Gukhoe-daero 62-gil, Yeongdeungpo-gu, Seoul, 07236, Korea

  • Privacy Policy
  • Terms of Service
  • Email Collection Prohibited

COPYRIGHT © INTOINWORLD, ALL RIGHT RESERVED